• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Oncologic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies = 3
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 

 


Chairperson
Deborah Armstrong, MD
Expertise: Medical Oncology, Cancer Genetics
Term: 05/17/2011 – 06/30/2015
Professor of Oncology
Johns Hopkins Kimmel Cancer Center
Johns Hopkins University School of Medicine
1650 Orleans Street, Room 190
Baltimore, Maryland 21231  
Designated Federal Officer
LT Caleb Briggs, PharmD

Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: ODAC@fda.hhs.gov

Harold J. Burstein, MD, PhD
Expertise: Medical Oncology
Term: 7/1/2014 – 6/30/2017
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, Massachusetts 02215

 

Aman Buzdar, MD
Expertise: Medical Oncology; Breast Cancer
Term: 11/29/2012 – 06/30/2015
Vice President Clinical Research
Professor of Medicine
Department of Breast Medical Oncology
M.D. Anderson Cancer Center
1515 Holcombe Blvd., Unit 1435
Houston, Texas 77030


Bernard F. Cole, PhD

Expertise: Biostatistics
Term: 8/28/2013 - 6/30/2017
Professor, Department of Mathematics and Statistics
University of Vermont
16 Colchester Avenue
Burlington, Vermont 05405


Louis F. Diehl, MD

Expertise: Hematology/Oncology
Term: 11/29/2012 – 06/30/2016
Professor of Medicine
Duke University Medical Center
Box 3872
Durham, North Carolina 27710


**Howard Fingert, MD, FACP
Expertise: Hematology/Oncology
Term: 04/04/2012-10/31/2015
Senior Medical Director, Clinical Research
Millennium, the Takeda Oncology Company
35 Landsdowne Street Room 350/5118
Cambridge, Massachusetts 02139


Tito Fojo, MD, PhD
Expertise: Medical Oncology
Term: 11/29/2012 – 06/30/2016
Senior Investigator
Director, Medical Oncology Fellowship Program
Medical Oncology Branch
Center for Cancer Research
National Cancer Institute
National Institutes of Health
9000 Rockville Pike, Building 10, Room 12N226
Bethesda, Maryland 20892

 

James Liebmann, MD
Expertise: Medical Oncology
Term: 11/29/2012 – 06/30/2015
Assistant Professor of Medicine
Department of Medicine
University of Massachusetts
55 Lake Avenue North
Worcester, Massachusetts 01655


Michael Menefee, MD

Expertise: Medical Oncology
Term: 11/29/2012 – 06/30/2016
Assistant Professor
Division of Hematology and Oncology
Mayo Clinic
4500 San Pablo Road
Jacksonville, Florida 32224

 

Bruce J. Roth, MD
Expertise: Medical Oncology,
Term: 7/1/2014 – 6/30/2018
Professor of Medicine
Division of Oncology
Washington University School of Medicine
660 S. Euclid Avenue
St. Louis, Missouri 63110

 

*Jane Zones, PhD
Expertise: Medical Sociology, Health Policy
Term: 2/2/2012 - 6/30/2015
Member, Former Board Member
Breast Cancer Action
National Women's Health Network
San Francisco, California  94122


* Consumer Representative
** Industry Representative, non voting